The Effects of IMA-026 on Allergen-Induced Airway Responses and Airway Inflammation in Subjects With Mild Atopic Asthma.
Phase of Trial: Phase I
Latest Information Update: 05 Jun 2009
At a glance
- Drugs IMA 026 (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- 05 Jun 2009 Actual initiation date (Jun 2009) added as reported by ClinicalTrials.gov.
- 05 Jun 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 26 Aug 2008 New trial record.